Baker Bros. Advisors’s IVERIC bio ISEE Stock Holding History
Bought
Maintained
Sold
Other funds holding ISEE
Baker Bros. Advisors's ISEE Position: Q3 2021 in Review
Baker Bros. Advisors sold out of IVERIC bio (ISEE) in Q3 2021, closing a stake of 1,406,037 shares — an estimated $8.87M sold.
Baker Bros. Advisors first reported a position in ISEE in Q4 2013 and held it in 19 quarters. The position peaked at $9.7M in Q4 2020. 149 funds tracked by Wall St. Rank hold ISEE as of Q3 2021.
- Baker Bros. Advisors reported no remaining IVERIC bio position as of Q3 2021 after selling out during the quarter.
- Baker Bros. Advisors sold 1,406,037 IVERIC bio shares in Q3 2021, an estimated $8.87M.
- Baker Bros. Advisors first reported a position in IVERIC bio in Q4 2013 and held it in 19 quarters.
- Baker Bros. Advisors's IVERIC bio position peaked at $9.7M in Q4 2020.
- 149 funds tracked by Wall St. Rank held IVERIC bio as of Q3 2021.
Based on Baker Bros. Advisors's 13F filing for Q3 2021, filed 15 Nov 2021.